Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 23% ± 7% | |
platelet | 7 studies | 24% ± 8% | |
plasmacytoid dendritic cell | 7 studies | 23% ± 6% | |
epithelial cell | 5 studies | 31% ± 10% | |
goblet cell | 5 studies | 23% ± 9% | |
astrocyte | 4 studies | 25% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% | |
ciliated cell | 3 studies | 18% ± 2% | |
fibroblast | 3 studies | 25% ± 4% | |
GABAergic neuron | 3 studies | 37% ± 1% | |
glutamatergic neuron | 3 studies | 41% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 5% | |
dendritic cell | 3 studies | 28% ± 7% | |
megakaryocyte | 3 studies | 36% ± 5% | |
basal cell | 3 studies | 22% ± 1% | |
transit amplifying cell | 3 studies | 21% ± 7% | |
oligodendrocyte | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2777.29 | 1445 / 1445 | 100% | 35.79 | 183 / 183 |
intestine | 100% | 3376.84 | 966 / 966 | 100% | 41.38 | 527 / 527 |
lung | 100% | 3224.27 | 578 / 578 | 100% | 29.79 | 1155 / 1155 |
ovary | 100% | 3018.58 | 180 / 180 | 100% | 22.95 | 430 / 430 |
pancreas | 100% | 5157.53 | 328 / 328 | 100% | 33.33 | 178 / 178 |
stomach | 100% | 2597.42 | 359 / 359 | 100% | 38.95 | 286 / 286 |
thymus | 100% | 3146.62 | 653 / 653 | 100% | 25.30 | 604 / 605 |
breast | 100% | 2921.98 | 459 / 459 | 100% | 25.41 | 1116 / 1118 |
prostate | 100% | 3233.30 | 245 / 245 | 100% | 26.87 | 501 / 502 |
uterus | 100% | 2957.22 | 170 / 170 | 100% | 33.71 | 458 / 459 |
bladder | 100% | 2722.19 | 21 / 21 | 100% | 28.66 | 502 / 504 |
kidney | 100% | 2732.67 | 89 / 89 | 99% | 26.19 | 895 / 901 |
brain | 99% | 1959.61 | 2624 / 2642 | 100% | 26.42 | 705 / 705 |
skin | 100% | 4405.08 | 1809 / 1809 | 99% | 37.92 | 468 / 472 |
adrenal gland | 100% | 2611.96 | 258 / 258 | 97% | 20.87 | 223 / 230 |
liver | 100% | 1471.61 | 225 / 226 | 95% | 13.25 | 387 / 406 |
adipose | 100% | 2889.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 34.43 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.13 | 29 / 29 |
spleen | 100% | 3123.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.25 | 1 / 1 |
muscle | 100% | 2121.25 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2208.07 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2131.79 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 2071.19 | 884 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010815 | Biological process | bradykinin catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0030145 | Molecular function | manganese ion binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070006 | Molecular function | metalloaminopeptidase activity |
GO_0004177 | Molecular function | aminopeptidase activity |
Gene name | XPNPEP1 |
Protein name | X-prolyl aminopeptidase 1 Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) |
Synonyms | XPNPEPL XPNPEPL1 |
Description | FUNCTION: Metalloaminopeptidase that catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro . Contributes to the degradation of bradykinin . . |
Accessions | Q5T6H2 Q5T6H7 Q5T6H3 ENST00000369683.5 ENST00000403138.6 ENST00000502935.6 [Q9NQW7-3] ENST00000423625.1 ENST00000322238.12 [Q9NQW7-4] Q9NQW7 |